Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension

Conclusions: This study showed that OLM/AML/HCTZ reduced blood pressure and significantly increased blood pressure control whilst improving patients’ HRQoL. Achieving blood pressure control, amount of concomitant medication and dosage strength of antihypertensive impacted on patients’ HRQoL.

http://www.hqlo.com/content/13/1/24

Source: BioMed Central - February 21, 2015 Category: Journals (General) Authors: Pedro Marques da SilvaUwe HaagJulian F GuestJohn E BrazierMarco Soro Source Type: research